Literature DB >> 30497214

The cost of hydrocephalus: a cost-effectiveness model for evaluating surgical techniques.

Jaims Lim1,2, Alan R Tang1,3, Campbell Liles1,2, Alexander A Hysong1,2, Andrew T Hale1,2, Christopher M Bonfield1,4, Robert P Naftel1,4, John C Wellons1,4, Chevis N Shannon1,4.   

Abstract

In BriefThe authors analyzed the costs associated with the three different procedures used to treat hydrocephalus in the pediatric population. They believe this study highlights the importance of patient-specific treatment decisions that are based on etiology and previous intervention. The patient-specific medical characteristics are a driving force in the cost of care.

Entities:  

Keywords:  CPC = choroid plexus cauterization; CSF = cerebrospinal fluid; CSF diversion; DALY = disability-adjusted life year; ETV = endoscopic third ventriculostomy; ICER = incremental cost-effectiveness ratio; NICU = neonatal intensive care unit; PHH = posthemorrhagic hydrocephalus; QALY = quality-adjusted life year; TCH = total costs of hospitalization; VP = ventriculoperitoneal; VPS = VP shunting; choroid plexus cauterization; cost-effectiveness; endoscopic third ventriculostomy; hydrocephalus; ventriculoperitoneal shunting

Mesh:

Year:  2018        PMID: 30497214     DOI: 10.3171/2018.6.PEDS17654

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  6 in total

1.  Endoscopic third ventriculostomy inpatient failure rates compared with shunting in post-hemorrhagic hydrocephalus of prematurity.

Authors:  Evan Luther; David McCarthy; Shaina Sedighim; Toba Niazi
Journal:  Childs Nerv Syst       Date:  2019-12-20       Impact factor: 1.475

2.  Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric and adult population: a systematic review and meta-analysis.

Authors:  Apurva Pande; Nayan Lamba; Marco Mammi; Paulos Gebrehiwet; Alyssa Trenary; Joanne Doucette; Stefania Papatheodorou; Adomas Bunevicius; Timothy R Smith; Rania A Mekary
Journal:  Neurosurg Rev       Date:  2020-05-31       Impact factor: 3.042

3.  Multi-omic analysis elucidates the genetic basis of hydrocephalus.

Authors:  Andrew T Hale; Lisa Bastarache; Diego M Morales; John C Wellons; David D Limbrick; Eric R Gamazon
Journal:  Cell Rep       Date:  2021-05-04       Impact factor: 9.423

Review 4.  Infant hydrocephalus: what valve first?

Authors:  Benjamin J Hall; Conor S Gillespie; Geraint J Sunderland; Elizabeth J Conroy; Dawn Hennigan; Michael D Jenkinson; Benedetta Pettorini; Conor Mallucci
Journal:  Childs Nerv Syst       Date:  2021-08-17       Impact factor: 1.475

Review 5.  Hydrocephalus: historical analysis and considerations for treatment.

Authors:  Alexandra Hochstetler; Jeffrey Raskin; Bonnie L Blazer-Yost
Journal:  Eur J Med Res       Date:  2022-09-01       Impact factor: 4.981

6.  Inference of Diagnostic Markers and Therapeutic Targets From CSF Proteomics for the Treatment of Hydrocephalus.

Authors:  Arie Horowitz; Pascale Saugier-Veber; Vianney Gilard
Journal:  Front Cell Neurosci       Date:  2020-10-21       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.